Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil

Detalhes bibliográficos
Autor(a) principal: Carvalho, Flavio de
Data de Publicação: 2023
Outros Autores: Brandão, Luciana Gomes Pedro, Varela, Margaret Catoia, Tuyama, Mari, Correa, Danusa Ferreira, Santos, Ananza Taina da Silva, Lemos, Alberto dos Santos de, Costa, Marcellus Dias da, Cerbino-Neto, José, Brasil, Pedro Emmanuel Alvarenga Americano do
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/58975
Resumo: Contributors: F. Carvalho contributed to the study design, data collection, and writing; and approved the final version. L. G. P. Brandão contributed to the study design, data collection, writing, and review; and approved the final version. M. C. Varela contributed to the study design, data collection, and review; and approved the final version. M. Tuyama contributed to the data collection, and reviewed; and approved the final version. D. F. Correa contributed to the data collection, and review; and approved the final version. A. T. S. Santos contributed to the data collection, and review; and approved the final version. A. S. Lemos contributed to the data collection, and review; and approved the final version. M. D. Costa contributed to the study design, data collection, and review; and approved the final version. J. Cerbino-Neto contributed to the study design, and review; and approved the final version. P. E. A. A. Brasil contributed to the study design, data analysis, and writing; and approved the final version.
id CRUZ_08e59c8eab6979da7cc19c12f86213b6
oai_identifier_str oai:www.arca.fiocruz.br:icict/58975
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Carvalho, Flavio deBrandão, Luciana Gomes PedroVarela, Margaret CatoiaTuyama, MariCorrea, Danusa FerreiraSantos, Ananza Taina da SilvaLemos, Alberto dos Santos deCosta, Marcellus Dias daCerbino-Neto, JoséBrasil, Pedro Emmanuel Alvarenga Americano do2023-06-07T23:59:47Z2023-06-07T23:59:47Z2023CARVALHO, Flavio de et al. Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil. Cadernos de Saúde Pública, Rio de Janeiro, v. 39, n. 2, p. 1-15, 2023.0102-311Xhttps://www.arca.fiocruz.br/handle/icict/5897510.1590/0102-311XEN0755221678-4464Contributors: F. Carvalho contributed to the study design, data collection, and writing; and approved the final version. L. G. P. Brandão contributed to the study design, data collection, writing, and review; and approved the final version. M. C. Varela contributed to the study design, data collection, and review; and approved the final version. M. Tuyama contributed to the data collection, and reviewed; and approved the final version. D. F. Correa contributed to the data collection, and review; and approved the final version. A. T. S. Santos contributed to the data collection, and review; and approved the final version. A. S. Lemos contributed to the data collection, and review; and approved the final version. M. D. Costa contributed to the study design, data collection, and review; and approved the final version. J. Cerbino-Neto contributed to the study design, and review; and approved the final version. P. E. A. A. Brasil contributed to the study design, data analysis, and writing; and approved the final version.Este estudo teve como objetivo estimar a soroprevalência do vírus da hepatite A, em indivíduos atendidos em uma clínica de medicina de viagem e imunização no Rio de Janeiro, Brasil, e desenvolver um modelo de predição para a soroprevalência do vírus da hepatite A. Esta pesquisa retrospectiva incluiu indivíduos sequencialmente de abril de 2011 a junho de 2019, em uma clínica de medicina de viagem e uma clínica de vacinação de população especial, que, por qualquer motivo, tem um resultado de quimioluminescência IgG antivírus da hepatite A . Os dados dos participantes foram verificados em prontuário eletrônico. Os dados foram divididos em desenvolvimento e validação, tomando 2018 como data limite da divisão. Um modelo linear generalizado elástico com distribuição binomial submetido a validação cruzada foi aplicado. Foram analisados 2.944 indivíduos atendidos. A soroprevalência geral do vírus da hepatite A foi de 67,8%. Profissionais de saúde, viajantes e contatantes de indivíduos imunocomprometidos apresentaram menor soroprevalência, variando de 40% a 55%, enquanto indivíduos com condições crônicas (coração, pulmão e fígado) tiveram soroprevalência variando de 89% a 94%. Os preditores retidos no modelo final foram sexo, idade, ano de nascimento, viajantes, HIV/aids, asplenia funcional, candidatos a transplante, comunicante domiciliar, imunossupressão relacionada ao câncer e profissionais de saúde. A área sob a curva foi de 0,836 e o erro máximo foi de 0,051. Os usuários podem fazer previsões com uma calculadora (https://pedrobrasil.shinyapps.io/INDWELL/). Os grupos com menor soroprevalência devem ser avaliados com mais cuidado quanto à necessidade de vacinação contra o vírus da hepatite A, mesmo quando procuram clínicas de vacinação para outros fins.The objectives were to estimate hepatitis A virus seroprevalence in subjects attending to a travel medicine and immunization clinic in Rio de Janeiro, Brazil, and to develop a prediction model for hepatitis A virus seroprevalence. This retrospective research included individuals sequentially from April 2011 to June 2019 at a travel medicine and special population immunization clinic with an anti-hepatitis A virus IgG chemiluminescence result. Participants’ data were verified via electronic medical records. Data were split into development and validation set taking 2018 as the date break. A cross-validated elastic generalized linear model with binomial distribution was performed. In total, 2,944 subjects were analyzed. Hepatitis A virus overall seroprevalence was 67.8%. Health professionals, travelers, and those who had contact with immunocompromised subjects had lower seroprevalence (40%-55%), whereas subjects with chronic conditions (heart, lung, and liver) ranged from 89% to 94%. The retained predictors in the final model were sex, age, year of birth, travelers, HIV/AIDS, spleen dysfunction, transplant candidates, household communicators, cancer-related immunosuppression, health care professionals. Area under the curve was 0.836 and maximum error was 0.051. Users can make predictions with the following calculator: https://pedrobrasil.shinyapps.io/INDWELL/. The groups with lower seroprevalence should be evaluated more carefully regarding need for hepatitis A virus vaccination even when they seek immunization clinics for other purposes.Los objetivos del estudio son estimar la seroprevalencia de hepatitis A en sujetos que asisten a una clínica de medicina para viajeros e inmunización en Río de Janeiro, Brasil, y desarrollar un modelo de predicción de la seroprevalencia de hepatitis A. Esta investigación de seguimiento retrospectivo incluyó a individuos de forma secuencial desde abril de 2011 hasta junio de 2019 en una clínica de medicina para viajeros y de vacunación de poblaciones especiales que por cualquier motivo tienen un resultado de quimioluminiscencia IgG anti-hepatitis A. Los datos de los participantes se verificaron en los registros médicos electrónicos. Los datos se dividieron en conjunto de desarrollo y validación tomando 2018 como fecha de corte. Se realizó un modelo lineal generalizado validado cruzado elástico con distribución binomial. Se analizaron un total de 2.944 sujetos atendidos. La seroprevalencia global del hepatitis A fue del 67,8%. Los profesionales sanitarios, los viajeros y las personas en contacto con sujetos inmunodeprimidos presentaron una seroprevalencia más baja, que osciló entre el 40% y el 55%, mientras que los sujetos con afecciones crónicas (cardíacas, pulmonares y hepáticas) presentaron una seroprevalencia que varió entre el 89% y el 94%. Los predictores retenidos en el modelo final fueron el sexo, la edad, el año de nacimiento, los viajeros, el VIH/SIDA, la disfunción del bazo, los candidatos a trasplante, los comunicadores domésticos, la inmunosupresión relacionada con el cáncer y los profesionales sanitarios. Su área bajo la curva fue de 0,836 y el error máximo de 0,051. Los usuarios pueden hacer predicciones con una calculadora (https://pedrobrasil.shinyapps.io/INDWELL/). Los grupos con menor seroprevalencia deben ser evaluados más cuidadosamente en cuanto a la necesidad de vacunación contra hepatitis A, incluso cuando acudan a las clínicas de vacunación con otros fines.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.engFiocruz/ENSPHepatite AMedicina de ViagemDoença CrônicaPessoal de SaúdeProgramas de ImunizaçãoHepatitis ATravel MedicineChronic DiseaseHealth PersonnelImmunization ProgramsHepatitis AMedicina del ViajeroEnfermedad CrónicaPersonal de SaludProgramas de InmunizaciónHepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, BrazilSoroprevalência da hepatite A entre populações especiais na Região Metropolitana do Rio de Janeiro, BrasilSeroprevalencia de la hepatitis A en poblaciones especiales em el Área Metropolitana de Río de Janeiro, Brasilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/58975/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALve_Flavio_Carvalho_etal_INI_2023.pdfve_Flavio_Carvalho_etal_INI_2023.pdfapplication/pdf454979https://www.arca.fiocruz.br/bitstream/icict/58975/2/ve_Flavio_Carvalho_etal_INI_2023.pdfc9b2089f5b12bb79291c7210041dc1d1MD52icict/589752023-06-07 20:59:48.444oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-06-07T23:59:48Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
dc.title.alternative.en_US.fl_str_mv Soroprevalência da hepatite A entre populações especiais na Região Metropolitana do Rio de Janeiro, Brasil
Seroprevalencia de la hepatitis A en poblaciones especiales em el Área Metropolitana de Río de Janeiro, Brasil
title Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
spellingShingle Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
Carvalho, Flavio de
Hepatite A
Medicina de Viagem
Doença Crônica
Pessoal de Saúde
Programas de Imunização
Hepatitis A
Travel Medicine
Chronic Disease
Health Personnel
Immunization Programs
Hepatitis A
Medicina del Viajero
Enfermedad Crónica
Personal de Salud
Programas de Inmunización
title_short Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
title_full Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
title_fullStr Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
title_full_unstemmed Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
title_sort Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil
author Carvalho, Flavio de
author_facet Carvalho, Flavio de
Brandão, Luciana Gomes Pedro
Varela, Margaret Catoia
Tuyama, Mari
Correa, Danusa Ferreira
Santos, Ananza Taina da Silva
Lemos, Alberto dos Santos de
Costa, Marcellus Dias da
Cerbino-Neto, José
Brasil, Pedro Emmanuel Alvarenga Americano do
author_role author
author2 Brandão, Luciana Gomes Pedro
Varela, Margaret Catoia
Tuyama, Mari
Correa, Danusa Ferreira
Santos, Ananza Taina da Silva
Lemos, Alberto dos Santos de
Costa, Marcellus Dias da
Cerbino-Neto, José
Brasil, Pedro Emmanuel Alvarenga Americano do
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Carvalho, Flavio de
Brandão, Luciana Gomes Pedro
Varela, Margaret Catoia
Tuyama, Mari
Correa, Danusa Ferreira
Santos, Ananza Taina da Silva
Lemos, Alberto dos Santos de
Costa, Marcellus Dias da
Cerbino-Neto, José
Brasil, Pedro Emmanuel Alvarenga Americano do
dc.subject.other.en_US.fl_str_mv Hepatite A
Medicina de Viagem
Doença Crônica
Pessoal de Saúde
Programas de Imunização
topic Hepatite A
Medicina de Viagem
Doença Crônica
Pessoal de Saúde
Programas de Imunização
Hepatitis A
Travel Medicine
Chronic Disease
Health Personnel
Immunization Programs
Hepatitis A
Medicina del Viajero
Enfermedad Crónica
Personal de Salud
Programas de Inmunización
dc.subject.en.en_US.fl_str_mv Hepatitis A
Travel Medicine
Chronic Disease
Health Personnel
Immunization Programs
dc.subject.es.en_US.fl_str_mv Hepatitis A
Medicina del Viajero
Enfermedad Crónica
Personal de Salud
Programas de Inmunización
description Contributors: F. Carvalho contributed to the study design, data collection, and writing; and approved the final version. L. G. P. Brandão contributed to the study design, data collection, writing, and review; and approved the final version. M. C. Varela contributed to the study design, data collection, and review; and approved the final version. M. Tuyama contributed to the data collection, and reviewed; and approved the final version. D. F. Correa contributed to the data collection, and review; and approved the final version. A. T. S. Santos contributed to the data collection, and review; and approved the final version. A. S. Lemos contributed to the data collection, and review; and approved the final version. M. D. Costa contributed to the study design, data collection, and review; and approved the final version. J. Cerbino-Neto contributed to the study design, and review; and approved the final version. P. E. A. A. Brasil contributed to the study design, data analysis, and writing; and approved the final version.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-06-07T23:59:47Z
dc.date.available.fl_str_mv 2023-06-07T23:59:47Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv CARVALHO, Flavio de et al. Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil. Cadernos de Saúde Pública, Rio de Janeiro, v. 39, n. 2, p. 1-15, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/58975
dc.identifier.issn.en_US.fl_str_mv 0102-311X
dc.identifier.doi.none.fl_str_mv 10.1590/0102-311XEN075522
dc.identifier.eissn.none.fl_str_mv 1678-4464
identifier_str_mv CARVALHO, Flavio de et al. Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil. Cadernos de Saúde Pública, Rio de Janeiro, v. 39, n. 2, p. 1-15, 2023.
0102-311X
10.1590/0102-311XEN075522
1678-4464
url https://www.arca.fiocruz.br/handle/icict/58975
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/ENSP
publisher.none.fl_str_mv Fiocruz/ENSP
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/58975/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/58975/2/ve_Flavio_Carvalho_etal_INI_2023.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
c9b2089f5b12bb79291c7210041dc1d1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324648189886464

Registros relacionados